Elmar Jaeckel
Overview
Explore the profile of Elmar Jaeckel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
1599
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Du W, Noyan F, McCallion O, Drosdek V, Kath J, Glaser V, et al.
Mol Ther
. 2025 Feb;
33(3):997-1013.
PMID: 39905729
Adoptive transfer of antigen-specific regulatory T cells (Tregs) is a promising strategy to combat immunopathologies in transplantation and autoimmune diseases. However, their low frequency in peripheral blood poses challenges for...
2.
Hupa-Breier K, Schenk H, Campos-Murguia A, Wellhoner F, Heidrich B, Dywicki J, et al.
Mol Metab
. 2025 Jan;
93:102104.
PMID: 39855563
Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease, especially in patients with severe obesity. However, current mouse models for MASLD do not...
3.
Stark H, Ho Q, Cross A, Alessandrini A, Bertaina A, Brennan D, et al.
Transplantation
. 2025 Jan;
PMID: 39800883
No abstract available.
4.
Vionnet J, Torres-Yaguana J, Miquel R, Abraldes J, Wall J, Kodela E, et al.
Am J Transplant
. 2024 Dec;
PMID: 39706366
The maintenance of stable allograft status in the absence of immunosuppression (IS), known as operational tolerance, can be achieved in a small proportion of liver transplant recipients, but we lack...
5.
Zhao X, Xu C, Bera C, Arisar F, Naghibzadeh M, Azhie A, et al.
Dig Dis Sci
. 2024 Dec;
70(2):543-551.
PMID: 39681747
Objective: Recent U.S. registry publications showed no improvement in long-term survival post-liver transplant in the last three decades. Cardiovascular disease was a leading cause of post-transplant mortality. This observation urged...
6.
Campos-Murguia A, Guetzlaff L, Bosselmann E, Engel B, Hartleben B, Wedemeyer H, et al.
Clin Transplant
. 2024 Nov;
38(11):e70039.
PMID: 39575514
Background And Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading indication for liver transplantation (LT), but also occurs after LT. The prevalence of de novo MASLD (dnMASLD) after...
7.
Magyar C, Perera S, Rajendran L, Li Z, Almugbel F, Feng S, et al.
Transplantation
. 2024 Nov;
PMID: 39531339
Background: Hepatocellular carcinoma (HCC) recurs after liver transplantation (LT) in ~17% of patients. We aimed to retrospectively compare the outcomes of patients treated with different tyrosine kinase inhibitors (TKIs) for...
8.
Seltrecht N, Hardtke-Wolenski M, Iordanidis K, Jonigk D, Galla M, Schambach A, et al.
Cells
. 2024 Jul;
13(14.
PMID: 39056797
Background: Solid organ transplantation is hindered by immune-mediated chronic graft dysfunction and the side effects of immunosuppressive therapy. Regulatory T cells (Tregs) are crucial for modulating immune responses post-transplantation; however,...
9.
Zheng K, Azhie A, You X, Naghibzadeh M, Tan E, Naimimohasses S, et al.
Diabetes Obes Metab
. 2024 Jul;
26(10):4261-4272.
PMID: 39056216
Aim: To investigate the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors in liver transplant (LT) recipients with diabetes. Methods: A single-centre, retrospective analysis...
10.
Li Z, Jones O, Magyar C, Claasen M, Ivanics T, Choi W, et al.
Ann Surg
. 2024 Jul;
PMID: 39041223
Objective: Assess the impact of having a living donor on waitlist outcomes and overall survival through an intention-to-treat analysis. Background: Living-donor liver transplantation (LDLT) offers an alternative to deceased donation...